2024
WHEN ALTERNATIVE HEALTH CLINICS GO WRONG; STRONG MUSCLES, WEAK HEART AND A CASE OF ANABOLIC STEROID ASSOCIATED CARDIOMYOPATHY
Gooding K, Pillai A, Tabtabai S. WHEN ALTERNATIVE HEALTH CLINICS GO WRONG; STRONG MUSCLES, WEAK HEART AND A CASE OF ANABOLIC STEROID ASSOCIATED CARDIOMYOPATHY. Journal Of The American College Of Cardiology 2024, 83: 3240. DOI: 10.1016/s0735-1097(24)05230-6.Peer-Reviewed Original Research
2023
Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities
Kim M, Aseltine R, Tabtabai S. Understanding the Burden of 30-Day Readmission in Patients With Both Primary and Secondary Diagnoses of Heart Failure: Causes, Timing, and Impact of Co-Morbidities. The American Journal Of Cardiology 2023, 210: 76-84. PMID: 37858595, DOI: 10.1016/j.amjcard.2023.09.086.Peer-Reviewed Original ResearchPredictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis
Kim M, Tabtabai S, Aseltine R. Predictors of 30-Day Readmission in Patients Hospitalized With Heart Failure as a Primary Versus Secondary Diagnosis. The American Journal Of Cardiology 2023, 207: 407-417. PMID: 37782972, DOI: 10.1016/j.amjcard.2023.08.111.Peer-Reviewed Original ResearchConceptsElixhauser co-morbidity indexHeart failureMultivariate logistic regressionCo-morbiditiesSecondary diagnosisPatients admitted with HFPatient co-morbiditiesAdmitted with HFDetrimental to patientsPopulation of patientsLogistic regressionCo-morbidity indexReadmission riskDiagnosis of HFSecondary diagnosis of HFNationwide Readmissions DatabaseCo-morbid complicationsRenal failureComparing patientsShort-term rehospitalizationHF patientsStatistically significant predictorsPredicting 30-day readmissionIncreased riskElixhauser co-morbiditiesReadmission Patterns In Patients Admitted With Primary Or Secondary Diagnosis Of Heart Failure
Kim M, Aseltine R, Tabtabai S. Readmission Patterns In Patients Admitted With Primary Or Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 682. DOI: 10.1016/j.cardfail.2022.10.337.Peer-Reviewed Original ResearchSecondary diagnosis of HFDiagnosis of HFSecondary diagnosisPrimary diagnosisRisk of hospital admissionSecondary diagnosis of heart failureReadmission ratesIndex admissionLower household incomePrimary diagnosis of HFComorbid conditionsPercentage of readmissionsEffects of comorbid conditionsHeart failureBackground Heart failurePublic health issueSystolic HFDiastolic HFNational Readmission DatabaseRisk of mortalityReduce HF readmissionsHospital characteristicsDiagnosis of heart failureCost of hospitalizationRisk comorbiditiesThe Presence Of Clinical COPD Predicts Mortality In Heart Failure Patient Population
Adeel M, Wakefield D, Soucier R, ZuWallack R, Tabtabai S. The Presence Of Clinical COPD Predicts Mortality In Heart Failure Patient Population. Journal Of Cardiac Failure 2023, 29: 643. DOI: 10.1016/j.cardfail.2022.10.237.Peer-Reviewed Original ResearchChronic obstructive pulmonary diseaseHFpEF patientsHFrEF patientsHeart failurePrognostic impact of chronic obstructive pulmonary diseaseMedian LOSDiagnosis groupsHF typePresence of chronic obstructive pulmonary diseaseClinical diagnosis of chronic obstructive pulmonary diseaseConcurrent chronic obstructive pulmonary diseaseKaplan-Meier survival curvesComorbid chronic obstructive pulmonary diseaseDiagnosis of chronic obstructive pulmonary diseaseHeart failure patient populationCalcium channel blockersCox regression analysisClinical chronic obstructive pulmonary diseaseIn-hospital mortalityChronic obstructive pulmonary disease diagnosisDiagnosis of HFYears of ageImpact of chronic obstructive pulmonary diseaseObstructive pulmonary diseasePrognostic impactPredicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart Failure
Kim M, Aseltine R, Tabtabai S. Predicting 30-day Readmission In Patients With A Primary Versus Secondary Diagnosis Of Heart Failure. Journal Of Cardiac Failure 2023, 29: 681. DOI: 10.1016/j.cardfail.2022.10.335.Peer-Reviewed Original ResearchDiagnosis of HFNational Readmission DatabaseRenal failureRisk scoreCohort of HF patientsHigh riskMultivariate logistic regression analysisReadmission ratesAssociated with younger ageHigher risk of mortalityAdmitted with HFCompared patient demographicsChronic pulmonary diseasePopulation of patientsMultivariate logistic regressionThirty-day readmission ratesLogistic regression analysisElixhauser comorbiditiesRisk of mortalityReadmission riskEvidence-based clinical decision supportHigher risk of readmissionDeficiency anemiaPatient demographicsRisk of readmissionEffect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure
Mentz R, Anstrom K, Eisenstein E, Sapp S, Greene S, Morgan S, Testani J, Harrington A, Sachdev V, Ketema F, Kim D, Desvigne-Nickens P, Pitt B, Velazquez E, Adams K, Bhatt K, DeWald T, Axsom K, Murthy S, Rich J, Testani J, Smith B, Vader J, McCulloch M, Skopicki H, Psotka M, Heroux A, Lala-Trindade A, Stevens G, Tang W, Lev Y, William P, Eberly A, Gottleib S, Haught W, Grafton G, Larned J, Tejwani L, Mody F, Krim S, Robinson M, Fang J, Adler A, Bell A, Banerjee D, Ruiz Duque E, Mizyed A, Rommel J, Arhinful J, Goyal P, Hall M, Hummel S, Shetty S, Haas D, Vilaro J, Alexy T, Herre J, Clark J, Ambrosy A, Gaglianello N, Ramasubbu K, Meadows J, Tabtabai S, Sherwood M, Hasni S, D'Urso M, Muneer B, Dunlap S, Davis W, Friedman D, Guglin M, Ferguson A, Abbate A, Smart F. Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure. JAMA 2023, 329: 214-223. PMID: 36648467, PMCID: PMC9857435, DOI: 10.1001/jama.2022.23924.Peer-Reviewed Original ResearchConceptsCause mortalityHeart failureTorsemide groupFurosemide groupTotal hospitalizationsCause hospitalizationEffects of torsemideDiuretic strategyPrespecified subgroupsSecondary outcomesEjection fractionMedian agePrimary outcomeHospitalizationMAIN OUTCOMEPatientsFurosemideMortalityMonthsTorsemidePrimary hypothesisSignificant differencesFinal dateOutcomesTrials
2022
The Effect of COPD Co-Morbidity on Mortality in CHF
Amann D, Akdogan R, Kaur A, ZuWallack R, Wakefield D, Tabtabai S. The Effect of COPD Co-Morbidity on Mortality in CHF. 2022, a4021-a4021. DOI: 10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4021.Peer-Reviewed Original ResearchEarly Palliative Care Consultation Reduces Length Of Stay And Cost In Patients Hospitalized With Acute Decompensated Heart Failure
Esstman B, Cyr P, Wakefield D, Soucier R, Tabtabai S. Early Palliative Care Consultation Reduces Length Of Stay And Cost In Patients Hospitalized With Acute Decompensated Heart Failure. Journal Of Cardiac Failure 2022, 28: s39-s40. DOI: 10.1016/j.cardfail.2022.03.106.Peer-Reviewed Original ResearchPalliative care consultationLength of stayEarly palliative care involvementAssociated with increased health care costsNon-cancer diagnosesPalliative care involvementReduce length of staySt Francis HospitalAcute decompensated heart failureHealth care costsReduced quality of lifeQuality of lifePredictors of length of stayAssociated with reduced lengthCare consultationPalliative careHigher severity of illnessCare involvementProlonged length of stayMedian length of staySeverity of illnessCare costsIn-hospital mortalityPractice advisoryAssociated with decreased LOS
2020
A Dedicated Guideline Directed Medical Therapy Clinic Improves Quality of Care and Outcomes In Patients with Heart Failure and Reduced Ejection Fraction
Tiu J, Balakumaran K, Barry M, Cipriani K, Kearney L, Oranefo J, Kim M, Tabtabai S. A Dedicated Guideline Directed Medical Therapy Clinic Improves Quality of Care and Outcomes In Patients with Heart Failure and Reduced Ejection Fraction. Journal Of Cardiac Failure 2020, 26: s133. DOI: 10.1016/j.cardfail.2020.09.386.Peer-Reviewed Original ResearchTarget doses of beta-blockersProportion of patientsDoses of beta-blockersTarget doseMinnesota Living with Heart Failure QuestionnaireHeart failure parametersEjection fractionHeart failurePHQ-9 scoresBeta-blockersLV end-diastolic diameterAssociated with significant morbidityNYHA class IIEnd-diastolic diameterReduced ejection fractionNon-ischemic cardiomyopathyRegimen of medicationCongestive heart failureMedian PHQ-9 scoreResults of landmark trialsHeart failure diagnosisEnrollment of patientsImproving clinical outcomesHeart Failure QuestionnaireMonths post-intervention
2019
RACIAL DISPARITIES IN WOMEN ADMITTED WITH PERIPARTUM CARDIOMYOPATHY: NIS DATABASE ANALYSIS
Krishnan A, Tandon V, Ramanathan R, Mukarram O, Tabtabai S, Balakumaran K. RACIAL DISPARITIES IN WOMEN ADMITTED WITH PERIPARTUM CARDIOMYOPATHY: NIS DATABASE ANALYSIS. CHEST Journal 2019, 156: a1130. DOI: 10.1016/j.chest.2019.08.1032.Peer-Reviewed Original ResearchCharacteristics of Elderly Listed for Heart Transplantation: An Analysis of the Scientific Registry of Transplant Recipients
Balakumaran K, Baker W, Tandon V, Joshi S, Tabtabai S, Jaiswal A. Characteristics of Elderly Listed for Heart Transplantation: An Analysis of the Scientific Registry of Transplant Recipients. Journal Of Cardiac Failure 2019, 25: s15. DOI: 10.1016/j.cardfail.2019.07.046.Peer-Reviewed Original ResearchHeart transplantationScientific Registry of Transplant RecipientsNon-elderlyElderly groupElderly patientsProportion of elderly patientsCombined organ transplantationOrthotopic heart transplantationScientific RegistryUNOS Status 1ATransplant recipientsIschemic cardiomyopathyAdult patientsBaseline characteristicsOrgan transplantationStatus 1AElderly candidatesTransplant centersTransplantationPatientsAge groupsProportion of malesMortalityCharacteristics of eldersAgeAchievement of Target Doses of Guideline-Directed Medical Therapy Prior to Cardiac Resynchronization Therapy is Suboptimal
Balakumaran K, Goldgrab D, Krishnan A, Shah N, Kim M, Rabieihashemi S, Cipriani K, Pickett C, Tabtabai S. Achievement of Target Doses of Guideline-Directed Medical Therapy Prior to Cardiac Resynchronization Therapy is Suboptimal. Journal Of Cardiac Failure 2019, 25: s128. DOI: 10.1016/j.cardfail.2019.07.366.Peer-Reviewed Original ResearchGuideline directed medical therapyCardiac resynchronization therapyCardiac resynchronization therapy implantationHeart failureTarget doseTime of implantationCRT implantationResynchronization therapyMedical therapyDosing of guideline-directed medical therapyGuideline-directed medical therapyDirected medical therapyNYHA class IIIII heart failureDocumented atrial fibrillationProportion of patientsDevice-based treatmentBackground Heart failureBB therapyHF registryIschemic cardiomyopathyClinical characteristicsChart reviewDevice therapyAtrial fibrillationCLINICAL OVERLAP BETWEEN MYOPERICARDITIS AND STRESS INDUCED CARDIOMYOPATHY: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE
Sharma T, Tigadi S, Khurana A, Tabtabai S. CLINICAL OVERLAP BETWEEN MYOPERICARDITIS AND STRESS INDUCED CARDIOMYOPATHY: A DIAGNOSTIC AND THERAPEUTIC CHALLENGE. Journal Of The American College Of Cardiology 2019, 73: 2586. DOI: 10.1016/s0735-1097(19)33192-4.Peer-Reviewed Original ResearchClinical Overlap Between Myopericarditis and Stress Induced Cardiomyopathy: A Diagnostic and Therapeutic Challenge
Sharma T, Tigadi S, Baldwin J, Tabtabai S. Clinical Overlap Between Myopericarditis and Stress Induced Cardiomyopathy: A Diagnostic and Therapeutic Challenge. American Journal Of Case Reports 2019, 20: 252-257. PMID: 30804319, PMCID: PMC6402271, DOI: 10.12659/ajcr.912169.Peer-Reviewed Original ResearchConceptsErythrocyte sedimentation rateEjection fractionApical ballooningPR depressionHistory of emotional stressElevated erythrocyte sedimentation rateNon-obstructive coronary diseaseNon-obstructive coronary arteriesDiagnosis of myopericarditisPleuritic chest painVentricular apical ballooningReduced ejection fractionT-wave inversionType of therapyFlu-like illnessSecondary to extensionNext 2 daysMasquerading presentationPleuritic painViral prodromeAcute myopericarditisChest painAtypical presentationMyocardial inflammationElectrocardiogram findings
2018
Updates in heart failure 30-day readmission prevention
Goldgrab D, Balakumaran K, Kim M, Tabtabai S. Updates in heart failure 30-day readmission prevention. Heart Failure Reviews 2018, 24: 177-187. PMID: 30488242, DOI: 10.1007/s10741-018-9754-4.Peer-Reviewed Original ResearchConceptsHospital Readmissions Reduction ProgramAffordable Care ActReduce health care costsReadmission ratesReduce short-term readmissionsReadmissions Reduction ProgramHF readmissionHealth care costsCare costsShort-term readmissionCare ActAdmission diagnosisPrevent heart failureReduction programsRemote hemodynamic monitoringReadmissionMedical therapyHeart failureHF patientsHemodynamic monitoringHospitalProgramImpaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease
Yeh D, Schmidt A, Eisman A, Serfas J, Naqvi M, Youniss M, Ryfa A, Khan A, Safi L, Tabtabai S, Bhatt A, Lewis G. Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease. Heart 2018, 104: 2044. PMID: 30030334, DOI: 10.1136/heartjnl-2017-312572.Peer-Reviewed Original ResearchConceptsCardiopulmonary exercise testingRV reserveRight ventricleHeart failureNew York Heart Association classPrimary composite clinical outcomeFirst-pass radionuclide ventriculographyPrevalence of heart failureRV ejection fractionRV systolic functionEvent-free survivalMedian follow-upCongenital heart diseaseReserve groupComposite clinical outcomeAdverse cardiac outcomesTertiary care centreRight ventricular reserveAdverse cardiovascular outcomesPredicting adverse cardiovascular outcomesSystolic function assessmentRV dilatationACHD populationPrognostic impactAsymptomatic patientsSick sinus syndrome in cardiac noncompaction
Nasir U, Balakumaran K, Tabtabai S, Pickett C, Meng J. Sick sinus syndrome in cardiac noncompaction. HeartRhythm Case Reports 2018, 4: 359-361. PMID: 30112287, PMCID: PMC6092599, DOI: 10.1016/j.hrcr.2018.05.001.Peer-Reviewed Original Research
2017
Acoustic speech analysis of patients with decompensated heart failure: A pilot study
Murton O, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Hillman R, Dec G, Ausiello D, Mehta D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: 2639-2640. DOI: 10.1121/1.5014673.Peer-Reviewed Original ResearchHeart failureIntracardiac filling pressuresDecompensated heart failureImpaired cardiac functionMean length of stayAverage weight lossLength of stayPeripheral edemaCardiac functionPrevent decompensationFilling pressurePatientsDecompensationMonitoring patientsEdemaWeight lossMean lengthInpatient treatmentEarly indicatorPilot studyChronic conditionsAcoustic speech analysisTreatmentAcoustic speech analysis of patients with decompensated heart failure: A pilot study
Murton O, Hillman R, Mehta D, Semigran M, Daher M, Cunningham T, Verkouw K, Tabtabai S, Steiner J, Dec G, Ausiello D. Acoustic speech analysis of patients with decompensated heart failure: A pilot study. The Journal Of The Acoustical Society Of America 2017, 142: el401-el407. PMID: 29092550, PMCID: PMC5724620, DOI: 10.1121/1.5007092.Peer-Reviewed Original ResearchConceptsHeart failureIntracardiac filling pressuresDecompensated heart failureSpeech analysisIndicators of HFAcoustic speech analysisSpeech breathing characteristicsDiuretic treatmentPeripheral edemaPilot studyFilling pressureCreaky voiceSpeech passagesPatientsMonitoring patientsSpeech respirationSpeechIncreasing fundamental frequencyEdemaSustained vowelsAcoustic measurements